If you need more lookups,
subscriptions start at $34 USD/month.
Per Källblad Location
Uppsala, SE
Per Källblad Work
2006 -now Co-Founder and CEO @
2004 -2007 Senior Scientist @
2000 -2004 Founding Scientist @
1995 -1996 Genome Curator @
Per Källblad Education
Stockholm University
School of Business
2004-2006
University of Cambridge
Ph.D. (Pharmacology and Drug Design)
1996-2000
University of Gothenburg
M.Sc. (Molecular Biology)
1991-1995
Université Grenoble Alpes
Cell Biology and Immunology
1993-1994
Per Källblad Skills
Drug Discovery
Drug Design
Molecular Modeling
Small Molecules
Medicinal Chemistry
Biochemistry
Protein Chemistry
Biotechnology
Molecular Biology
Drug Development
R&D
Lifesciences
Lead Change
Life Sciences
Biopharmaceuticals
Cell
High Throughput Screening
Pharmaceutical Industry
Chemistry
Research and Development (R&D)
Cell Biology
Leadership
Strategic Planning
Research and Development R&d
Per Källblad Summary
Per Källblad, based in Uppsala, SE, is currently a Co-Founder and CEO at Beactica Therapeutics. Per Källblad brings experience from previous roles at Medivir AB, De Novo Pharmaceuticals and European Bioinformatics Institute | EMBL-EBI. Per Källblad holds a 2004 - 2006 School of Business @ Stockholm University. With a robust skill set that includes Drug Discovery, Drug Design, Molecular Modeling, Small Molecules, Medicinal Chemistry and more. Per Källblad has 1 emails on RocketReach.
Looking for a different Per Källblad?
Find contact details for 700 million professionals.